Hickey David 4
4 · BECTON DICKINSON & CO · Filed Aug 17, 2022
Insider Transaction Report
Form 4
Hickey David
EVP & President, Life Sciences
Transactions
- Sale
Common Stock
2022-08-15$265.00/sh−475$125,875→ 3,331 total
Footnotes (1)
- [F1]Direct holdings reflect adjustments made in connection with the spin-off of Embecta Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person. This transaction was made pursuant to a 10b5-1 plan entered into on March 9, 2022.